Home > ASCO 2017 – Andrew Hendifar Interview – Part 2
Pancreatic Cancer

ASCO 2017 – Andrew Hendifar Interview – Part 2

Published Online: September 4th 2017

Dr Andrew Hendifar reviews the adverse events associated with PEGPH20 (pegvorhyaluronidase alfa), and the future application of PEGPH20 in different cancers

 

This video was supported by Halozyme.

 

Filmed at the American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, US, June 2017

Share this Video
Related Videos In Pancreatic Cancer
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar